Fighting viral infections and virus-driven tumors with cytotoxic CD4+ T cells

33Citations
Citations of this article
77Readers
Mendeley users who have this article in their library.

Abstract

CD4+ T cells have been and are still largely regarded as the orchestrators of immune responses, being able to differentiate into distinct T helper cell populations based on differentiation signals, transcription factor expression, cytokine secretion, and specific functions. Nonetheless, a growing body of evidence indicates that CD4+ T cells can also exert a direct effector activity, which depends on intrinsic cytotoxic properties acquired and carried out along with the evolution of several pathogenic infections. The relevant role of CD4+ T cell lytic features in the control of such infectious conditions also leads to their exploitation as a new immunotherapeutic approach. This review aims at summarizing currently available data about functional and therapeutic relevance of cytotoxic CD4+ T cells in the context of viral infections and virus-driven tumors.

Cite

CITATION STYLE

APA

Muraro, E., Merlo, A., Martorelli, D., Cangemi, M., Santa, S. D., Dolcetti, R., & Rosato, A. (2017, February 27). Fighting viral infections and virus-driven tumors with cytotoxic CD4+ T cells. Frontiers in Immunology. Frontiers Research Foundation. https://doi.org/10.3389/fimmu.2017.00197

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free